SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 810.23 |
| Enterprise Value ($M) | 1,170.20 |
| Book Value ($M) | 489.02 |
| Book Value / Share | 9.95 |
| Price / Book | 1.66 |
| NCAV ($M) | 66.39 |
| NCAV / Share | 1.35 |
| Price / NCAV | 12.20 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.11 |
| Return on Assets (ROA) | -0.10 |
| Return on Equity (ROE) | -0.18 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 11.16 |
| Current Ratio | 11.73 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 535.11 |
| Assets | 957.74 |
| Liabilities | 468.72 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 233.25 |
| Operating Income | -65.59 |
| Net Income | -99.59 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -0.76 |
| Cash from Investing | 36.05 |
| Cash from Financing | -23.80 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Brown Capital Management Llc | 13.79 | -2.94 | |
| 13G/A | Alger Associates Inc | 4.10 | -26.87 | |
| 13G | Cadian Capital Management, Lp | 7.10 | ||
| 13G/A | Vanguard Group Inc | 7.47 | 3.47 | |
| 13G | Morgan Stanley | 8.50 | ||
| 13G/A | BlackRock Inc. | 7.30 | 13.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 52,529 | 313,974 | 16.73 | |
| 78,383 | 230,889 | 33.95 | |
| 77,558 | 255,769 | 30.32 | |
| 109,698 | 171,974 | 63.79 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CVKD – Cadrenal Therapeutics, Inc. | CYCC – Cyclacel Pharmaceuticals, Inc. |
| CYCN – Cyclerion Therapeutics, Inc. | CYTH – Cyclo Therapeutics, Inc. |
| DARE – Daré Bioscience, Inc. |
Financial data and stock pages provided by
Fintel.io